Several brokerages have updated their recommendations and price targets on shares of Smith & Nephew (LON: SN) in the last few weeks:
- 8/6/2026 – Smith & Nephew had its price target lowered by Royal Bank Of Canada from GBX 1,350 to GBX 1,250. They now have a “sector perform” rating on the stock.
- 8/6/2026 – Smith & Nephew had its price target lowered by JPMorgan Chase & Co. from GBX 1,438 to GBX 1,290. They now have a “neutral” rating on the stock.
- 8/5/2026 – Smith & Nephew had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a GBX 1,500 price target on the stock.
- 7/30/2026 – Smith & Nephew had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a GBX 1,400 price target on the stock.
- 7/21/2026 – Smith & Nephew had its “buy” rating reaffirmed by Shore Capital Group Ltd. They now have a GBX 1,000 price target on the stock.
- 7/10/2026 – Smith & Nephew was downgraded by Citigroup Inc. to “buy”.
- 6/29/2026 – Smith & Nephew had its “sector perform” rating reaffirmed by Royal Bank Of Canada. They now have a GBX 1,350 price target on the stock.
- 6/11/2026 – Smith & Nephew had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a GBX 1,400 price target on the stock.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Featured Stories
- Five stocks we like better than Smith & Nephew
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.
